Yearly Archives: 2011
Functional characterization of mutations in inherited human cPLA? deficiency.
Authors: Reed KA, Tucker DE, Aloulou A, Adler D, Ghomashchi F, Gelb MH, Leslie CC, Oates JA, Boutaud O.
Citation: Biochemistry. 2011 Mar 15;50(10):1731-8.
Induction and comparison of SIV immunity in Ad5 na
Authors: Gabitzsch ES, Xu Y, Balint JP Jr, Balcaitis S, Sanders-Beer B, Jones FR.
Citation: Vaccine. 2011 Oct 19;29(45):8101-7.
An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.
Authors: Gabitzsch ES, Xu Y, Balcaitis S, Balint JP Jr, Jones FR.
Citation: Cancer Gene Ther. 2011 May;18(5):326-35.
MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
Authors: de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.
Citation: PLoS One. 2011;6(9):e24584.
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
Authors: Harvey TJ, Hennig IM, Shnyder SD, Cooper PA, Ingram N, Hall GD, Selby PJ, Chester JD.
Citation: Cancer Gene Ther. 2011 Nov;18(11):773-84. doi: 10.1038/cgt.2011.43.
Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.
Authors: Viet CT, Ye Y, Dang D, Lam DK, Achdjian S, Zhang J, Schmidt BL.
Citation: Pain. 2011 Oct;152(10):2323-32.
Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides.
Authors: Yue WY, Clark JJ, Fernando A, Domann F, Hansen MR.
Citation: Neuro Oncol. 2011 Sep;13(9):961-73.
Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox Therapy
Authors: Luksana Chaiswing, , Weixiong Zhong, and Terry D. Oberley
Citation: Cancers 2011, 3(3), 3557-3584
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities.
Authors: Berasi SP, Varadarajan U, Archambault J, Cain M, Souza TA, Abouzeid A, Li J, Brown CT, Dorner AJ, Seeherman HJ, Jelinsky SA.
Citation: Growth Factors. 2011 Aug;29(4):128-39.
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity.
Authors: Ono M, Inkson CA, Kilts TM, Young MF.
Citation: J Bone Miner Res. 2011 Jan;26(1):193-208.
References
Links
- Recombinant DNA and Gene Transfer Office of Biotechnology Activities http://www4.od.nih.gov/oba/Rdna.htm
- Aldevron http://www.aldevron.com/
- Bio Research Products http://www.bio-researchprod.com/home.html
- Elmira Biologicals Inc. http://www.elmirbiol.com
- Genetel Laboratories LLC http://www.genetel-lab.com/
- Midwest Bio Services http://www.midwestbioservices.com/
- Nature Technology Corporation http://www.natx.com
- Trans Ova Genetics http://www.transova.com/
Contact us
PO Box 525, North Liberty, IA 52317
Phone: 319-665-4190 | Fax: 319-665-4191
help@viraquest.com